News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Novo Holdings A/S
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
SC 13D/A
| Novo Holdings A/S reports a 12% stake in IO Biotech, Inc. |
| 08/03/2023 |
SC 13D/A
| Novo Holdings A/S reports a 4.4% stake in Cyteir Therapeutics, Inc. |
| 07/26/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/28/2023 |
SC 13D/A
| Novo Holdings A/S reports a 9.6% stake in Edgewise Therapeutics, Inc. |
| 05/15/2023 |
SC 13D/A
| Novo Holdings A/S reports a 10.2% stake in Reneo Pharmaceuticals, Inc. |
| 02/24/2023 |
SC 13D/A
| Novo Holdings A/S reports a 11.7% stake in LAVA Therapeutics N.V. |
| 01/04/2023 |
SC 13D/A
| Novo Holdings A/S reports a 0% stake in Bolt Biotherapeutics, Inc. |
| 12/28/2022 |
SC 13D/A
| Novo Holdings A/S reports a 6.7% stake in Bolt Biotherapeutics, Inc. |
| 10/24/2022 |
SC 13D/A
| Novo Holdings A/S reports a 4.6% stake in Milestone Pharmaceuticals Inc. |
| 10/03/2022 |
SC 13D/A
| Novo Holdings A/S reports a 12.9% stake in LAVA Therapeutics N.V. |
| 09/30/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/30/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/30/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/30/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/30/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/30/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/30/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/30/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/26/2022 |
SC 13D/A
| Novo Holdings A/S reports a 7% stake in Milestone Pharmaceuticals Inc. |
| 09/16/2022 |
SC 13D/A
| Novo Holdings A/S reports a 9.6% stake in Edgewise Therapeutics, Inc. |
| 08/18/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/02/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/22/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/15/2022 |
SC 13D/A
| Novo Holdings A/S reports a 9.8% stake in Bolt Biotherapeutics, Inc. |
| 06/03/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/03/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/26/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/11/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/02/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/08/2022 |
SC 13D/A
| Novo Holdings A/S reports a 6.9% stake in Mirum Pharmaceuticals, Inc. |
| 02/22/2022 |
SC 13D/A
| Novo Holdings A/S reports a 4.9% stake in Morphic Holding, Inc. |
| 01/31/2022 |
SC 13D/A
| Novo Holdings A/S reports a 4.9% stake in Aligos Therapeutics, Inc. |
| 01/27/2022 |
SC 13D/A
| Novo Holdings A/S reports a 14% stake in Reneo Pharmaceuticals, Inc. |
| 12/20/2021 |
SC 13D/A
| Novo Holdings A/S reports a 13.6% stake in Cyteir Therapeutics, Inc. |
|
|
|